Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease

Gastroenterology

Volumn 115, Issue 4, 1998, Pages 813-821

  Kirschner, B S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; MERCAPTOPURINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; COLITIS; CROHN DISEASE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; PANCREATITIS; PRIORITY JOURNAL; STEROID THERAPY; THROMBOCYTOPENIA; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 0031680256     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(98)70251-3     Document Type: Article

References (40)

1. BS Kirschner Ulcerative colitis and Crohn's disease in children. Diagnosis and management Gastroenterol Clin North Am 24 1995 99 117
2. AM Leichtner WD Jackson RJ Grand Crohn's disease WA Walker PR Durie JR Hamilton JA Walker-Smith JB Watkins Pediatric gastrointestinal disease: pathophysiology, diagnosis, management 1996 Mosby–Year Book St. Louis, MO 692 711
3. AM Leichtner WD Jackson RJ Grand Ulcerative colitis WA Walker PR Durie JR Hamilton JA Walker-Smith JB Watkins Pediatric gastrointestinal disease: pathophysiology, diagnosis, management 1996 Mosby–Year Book St. Louis, MO 712 726
4. BS Kirschner Consequences for growth and development in chronic inflammatory bowel disease Acta Paediatr Scand 366 1990 98 104
5. J Markowitz K Grancher J Rosa H Aiges F Daum Growth failure in pediatric inflammatory bowel disease J Pediatr Gastroenterol Nutr 16 1993 373 380
6. H Hildebrand J Karlberg B Kristiansson Longitudinal growth in children and adolescents with inflammatory bowel disease J Pediatr Gastroenterol Nutr 18 1994 165 173
7. RC Tripathi BS Kirschner M Kipp BJ Tripathi D Slotwiner MS Borismuth T Karrison JT Ernest Corticosteroid treatment for inflammatory bowel disease in pediatric patients increases intraocular pressure Gastroenterology 102 1992 1957 1961
8. RC Tripathi MA Kipp BJ Tripathi BS Kirschner MS Borismuth SK Shevell JT Ernest Ocular toxicity of prednisone in pediatric patients with inflammatory bowel disease Lens Eye Toxicity Res 9 1992 469 482
9. JS Hyams Extraintestinal manifestations of inflammatory bowel disease J Pediatr Gastroenterol Nutr 19 1994 7 21
10. BI Korelitz JL Glass N Wisch Long-term observations of children with ulcerative colitis treated with an immunosuppressive (6-mercaptopurine) (abstr) Gastroenterology 72 1977 A1083
11. J Markowitz J Rosa K Grancher H Aiges F Daum Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease Gastroenterology 99 1990 1347 1355
12. M Verhave HS Winter RJ Grand Azathioprine in the treatment of children with inflammatory bowel disease J Pediatr 117 1990 809 814
13. DM Gold MJ Pettei B Kessler LL Levine 6-Mercaptopurine (6-MP) in pediatric inflammatory bowel disease (abstr) Gastroenterology 104 1993 A708
14. J Markowitz K Grancher F Mandel F Daum Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition Am J Gastroenterol 88 1993 44 48
15. SA Saeed Integlia MR Valicenti R Berhane RJ Grand M Verhave Immunosuppressive therapy for children with inflammatory bowel disease: a retrospective study with long-term follow up (abstr) Gastroenterology 112 1997 A1079
16. J Ramakrishna N Langhans K Calenda RJ Grand M Verhave Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease J Pediatr Gastroenterol Nutr 22 1996 296 302
17. DH Present BI Korelitz N Wisch JL Glass DB Sachar BS Pasternack Treatment of Crohn's disease with 6-mercaptopurine N Engl J Med 302 1980 981 987
18. BI Korelitz DH Present Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease Dig Dis Sci 30 1985 58 64
19. K Ewe AG Press CC Singe M Stufler B Ueberschaer G Hommel K-HM zum Büschenfelde Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease Gastroenterology 105 1993 367 372
20. Y Bouhnik M Lémann JY Mary G Scemama G Tai C Matuchansky R Modigliani JC Rambaud Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine Lancet 347 1996 215 219
21. G D'Haens K Geboes E Ponette F Penninckx P Rutgeerts Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease Gastroenterology 12 1997 1475 1481
22. WJ Sandborn A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate Am J Gastroenterol 991 1996 423 433
23. AB Hawthorne PFA Logan CJ Hawkey PN Foster AT Axon ET Swarbrick SB Scott JE Lennard-Jones Randomised controlled trial of azathioprine withdrawal in ulcerative colitis Br Med J 305 1992 20 22
24. T Colonna BI Korelitz The role of leukopenia in the 6-mercaptopurine–induced remission of refractory Crohn's disease Am J Gastroenterol 89 1994 362 366
25. CJ Haber SJ Meltzer DH Present BI Korelitz Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease Gastroenterology 91 1986 982 986
26. DH Present SJ Meltzer MP Krumholz A Wolke BI Korelitz 6-Mercaptopurine in the management of inflammatory bowel disease: short and long-term toxicity Ann Intern Med 111 1989 641 649
27. WR Connell MA Kamm JK Ritchie JE Lennard-Jones Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years' experience Gut 34 1993 1081 1085
28. JK Keene DK Lowe JL Grosfeld JF Fitzgerald F Gonzales-Crussi Disseminated varicella complicating ulcerative colitis JAMA 239 1978 45 46
29. DE Deutsch AD Olson S Kraker CJ Dickinson Overwhelming varicella pneumonia with Crohn's disease treated with 6-mercaptopurine J Pediatr Gastroenterol Nutr 20 1995 351 353
30. AD Schwartz Cancer in children: an overview 2nd ed AR Moosa SC Schimpff MC Robson Comprehensive textbook of oncology Volume 2 1991 Williams & Wilkins Baltimore 1469 1475
31. AJ Greenstein R Gennuso DB Sachar T Heimann H Smith HD Janowitz AH Aufses Jr Extraintestinal cancers in inflammatory bowel disease Cancer 56 1985 2914 2921
32. AJ Greenstein GE Mullin JA Strauchen T Heimann HD Janowitz AH Aufses Jr DB Sachar Lymphoma in inflammatory bowel disease Cancer 69 1992 1119 1123
33. CF Mews DW Thomas FR Sinatra LC Pinter Brown Characterization of an extraintestinal lymphoma in a patient with Crohn's disease treated with 6-mercaptopurine Abstracts of the North American Society for Pediatric Gastroenterology and Nutrition 1991
34. L Larvol J-C Soule A Le Tourneau Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease (letter) N Engl J Med 331 1994 883 884
35. WR Connell MA Kamm M Dickson AM Balkwill JK Ritchie JE Lennard-Jones Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease Lancet 343 1994 1249 1252
36. BA Lashner Risk factors for small bowel cancer in Crohn's disease Dig Dis Sci 37 1992 1179 1184
37. J Markowitz F Daum SA Cohen M Glassman RD Holmes D Piccoli TM Rossi WR Treem MH Ulshen HS Winter Immunology of inflammatory bowel disease: summary of the proceedings of the subcommittee on immunosuppressive use in IBD J Pediatr Gastroenterol Nutr 12 1991 411 423
38. C Cuffari Y Théôret R Lahaie E Seidman 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity Gut 39 1996 401 406
39. WJ Sandborn WJ Tremaine Measurement of thiopurine methyl-transferase (TMPT) activity in patients with inflammatory bowel disease (IBD) does not predict side effects from treatment with 6-mercaptopurine (6-MP) or azathioprine (abstr) Gastroenterology 104 1993 A774
40. WJ Sandborn 6-MP metabolite levels: a potential guide to Crohn's disease therapy Gastroenterology 113 1997 690 692